Beyond its pain-relieving effects, conolidine has demonstrated a favorable safety margin in preclinical toxicology assessments. As opposed to opioids, which often cause respiratory despair at increased doses, conolidine has not made signs of major respiratory suppression. Furthermore, behavioral assessments in murine versions propose an absence of drug-looking for behaviors, https://nigels948yeb6.jts-blog.com/profile